Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV

Lancet HIV. 2021 Jun;8(6):e317-e318. doi: 10.1016/S2352-3018(21)00099-0.

¹ Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
² Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
³ Division of Infection and Immunity, University College London, London WC1E 6BT, UK; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
⁴ The Mortimer Market Centre, Department of HIV, CNWL NHS Foundation Trust, London, UK.
⁵ Institute for Global Health, University College London, London WC1E 6BT, UK; Department of HIV Medicine, Royal Free NHS Foundation Trust, London, UK.
⁶ Department of Immunology, Royal Free Campus, University College London, London WC1E 6BT, UK; Department of Infection and Immunity, Royal Free NHS Foundation Trust, London, UK.
⁷ Department of Medicine, University of Cambridge, Cambridge, UK.
⁸ Institute for Global Health, University College London, London WC1E 6BT, UK.
⁹ The Mortimer Market Centre, Department of HIV, CNWL NHS Foundation Trust, London, UK; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. Electronic address: dimitra.peppa@ndm.ox.ac.uk.
¹⁰ Division of Infection and Immunity, University College London, London WC1E 6BT, UK. Electronic address: l.mccoy@ucl.ac.uk.

No abstract available

Publication types